Increased knowledge regarding the latest data on use of non-vitamin K antagonist oral anticoagulants in the setting of cancer-associated thrombosis

Greater competence related to risk assessment for venous thromboembolism (VTE) recurrence in patients with cancer

Greater competence related to strategies to tailor long-term VTE treatment strategies in patients with cancer